On Monday, iRhythm Technologies Inc. (NASDAQ:IRTC) reported preliminary fourth quarter operational highlights.The digital health company anticipates full-year 2025 revenue to exceed the high end of the previously stated guidance range of $740 million provided in October 2025, driven by record revenue unit volume during the fourth quarter of 2025.The analysts estimated a consensus of $737.95 million.For fiscal year 2026, iRhythm expects revenue of approximately $870 million to $880 million, up approximately ...

For full year 2026, expect revenue of approximately $870 million to $880 million, or approximately 17% to 18% year-over-year growth, and anticipate adjusted EBITDA margin of approximately 11.5% to 12.5%. “2025 has been a transformative year for iRhythm (IRTC), with strong execution against our aspiration to drive best-in-class quality systems, record commercial volumes, over 25% year-over-year revenue growth, and achieving free cash flow positivity for the first time in company history,” said Quentin Black ...

SAN FRANCISCO, Jan. 12, 2026 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC) a leading digital health care company focused on creating trusted solutions that detect, predict, and prevent disease, today announced preliminary fourth quarter operational highlights and a business update at the 44th Annual J.P. Morgan Healthcare Conference. Recent Operational Highlights and Financial Outlook Anticipate full year 2025 revenue to exceed high end of previously stated guidance range of $740 million prov ...